Skip to main content

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Filings indexed 420 across all filing types
Latest filing 2026-04-28 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
2025年年度报告
Regulatory Filings
2026-04-28 Chinese
关于取得发明专利证书的公告
Regulatory Filings
2026-02-26 Chinese
2025年年度业绩快报公告
Regulatory Filings
2026-02-26 Chinese
2025年年度业绩预告公告
Regulatory Filings
2026-01-28 Chinese
股东减持股份结果公告
Regulatory Filings
2025-12-17 Chinese
对外捐赠公告
Regulatory Filings
2025-12-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.